The FDA has accepted a new drug application for AVP-825, an investigational drug-device combination product for the acute treatment of migraine.
http://ift.tt/1fstT13
http://ift.tt/1fstT13
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment